Tissue factor (coagulation factor III) inhibition by apolipoprotein A-II

Area of Science:

• Biochemistry
• Hematology
• Molecular Biology

Background:

• Apolipoprotein A-II (apoA-II) plays a role in lipid metabolism and has been implicated in regulating blood coagulation.
• Tissue factor (TF) initiates the extrinsic coagulation pathway by forming a complex with coagulation factor VIIa (FVIIa).
• Dysregulation of TF-FVIIa activity is associated with thrombotic disorders.

Purpose of the Study:

• To investigate the inhibitory effect of apoA-II on TF-mediated activation of coagulation factor X (FX) by FVIIa.
• To elucidate the kinetic mechanism by which apoA-II modulates TF-FVIIa activity.
• To understand the interaction between apoA-II, TF, and FVIIa in the coagulation cascade.

Main Methods:

• Coagulation assays were performed to measure FX activation by FVIIa in the presence and absence of apoA-II.
• Varying concentrations of FVIIa, FX, and apoA-II were used to determine the kinetic parameters (Vmax, Km, K1/2).
• TF-reconstituted vesicles were employed to mimic the physiological environment for TF-FVIIa complex formation.

Main Results:

• Apolipoprotein A-II significantly inhibited TF-FVIIa-catalyzed FX activation in a concentration-dependent manner.
• Increasing apoA-II concentrations decreased the reaction Vmax and increased the apparent K1/2 for FVIIa, indicating competitive inhibition.
• ApoA-II's inhibitory effect was diminished at higher FVIIa concentrations, suggesting FVIIa can protect TF from apoA-II.

Conclusions:

• Apolipoprotein A-II inhibits TF potentiation of FVIIa activity, likely by preventing the optimal association of TF with FVIIa.
• The findings suggest a novel regulatory role for apoA-II in the extrinsic coagulation pathway.
• Understanding this interaction could offer new therapeutic targets for managing thrombotic diseases.